T2	CHEM 98 110	Upadacitinib
T3	LIVB 114 129	sujetos adultos
T4	Age 122 129	adultos
T5	DISO 134 152	dermatitis atópica
#1	AnnotatorNotes T5	C0011615; Dermatitis, Atopic; Disease or Syndrome
T6	PROC 195 260	Estudio de fase 3b/4, aleatorizado, doble ciego y dosis flexibles
T7	Dose 245 260	dosis flexibles
T8	CHEM 264 276	upadacitinib
T9	LIVB 280 287	adultos
#2	AnnotatorNotes T9	C0001675; Adult; Age Group
T10	Age 280 287	adultos
T11	DISO 292 310	dermatitis atópica
#3	AnnotatorNotes T11	C0011615; Dermatitis, Atopic; Disease or Syndrome
T12	DISO 363 381	Dermatitis atópica
#4	AnnotatorNotes T12	C0011615; Dermatitis, Atopic; Disease or Syndrome
T13	LIVB 430 460	Sujetos masculinos o femeninos
T14	Age 461 477	≥ 18 y > 65 años
T15	LIVB 488 495	Sujetos
#5	AnnotatorNotes T15	C0681850; Study Subject; Group
T18	DISO 517 525	síntomas
#6	AnnotatorNotes T18	C1457887; Symptoms; Sign or Symptom
T19	Duration 538 553	al menos 3 años
T20	PROC 643 664	tratamiento sistémico
T21	PROC 697 718	tratamiento sistémico
T22	DISO 727 729	DA
T23	CHEM 788 804	inhibidor de JAK
T24	Neg_cue 807 809	No
T25	Negated 810 815	poder
T26	Neg_cue 818 820	no
T27	PROC 828 856	interrumpir los tratamientos
T28	Negated 828 856	interrumpir los tratamientos
T30	DISO 876 878	EA
#7	AnnotatorNotes T30	C0002395; Alzheimer's Disease; Disease or Syndrome | C0003507; Aortic Valve Stenosis; Disease or Syndrome | C0038013; Ankylosing spondylitis; Disease or Syndrome | C0947926; Alzheimer's disease (incl subtypes); Mental or Behavioral Dysfunction
T31	CHEM 912 924	medicamentos
#8	AnnotatorNotes T31	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0304228; Proprietary drug, NOS; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T32	Contraindicated 912 924	medicamentos
T33	PROC 947 958	tratamiento
#9	AnnotatorNotes T33	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	Spec_cue 1027 1035	pensando
T36	PHYS 1048 1058	embarazada
#10	AnnotatorNotes T36	C0032961; Pregnancy; Organism Function
T37	Speculated 1048 1058	embarazada
T43	PHYS 1006 1015	lactancia
T38	DISO 500 510	DA crónica
#11	AnnotatorNotes T38	Atopic dermatitis, chronic (MTHU003868) / Dermatitis, Atopic C0011615
#13	AnnotatorNotes T20	Systemic Therapy C1515119
#14	AnnotatorNotes T43	Lactation C0022925
T17	LIVB 974 990	Mujer embarazada
T1	PROC 46 94	Estudio para evaluar la flexibilidad de la dosis
T16	Route 655 664	sistémico
T29	Route 709 718	sistémico
